Get started
Emergent BioSolutions Inc.Emergent BioSolutions Inc.Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

EBS trade ideas

Emergent BioSolutions | Chart & Forecast SummaryKey Indicators on Trade Set Up in General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session - 60 Minutes Time Frame # Emergent BioSolutions - Based in Gaithersburg, Maryland | USA - Trend Line 1&2 | Exchange Of Context - WXY | Wave X | Point Of Control - Inverted Head & Shoulders | Directional Trend Based Bias Active Sessions on Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusion | Trade Plan Execution & Risk Management on Demand; Overall Consensus | Neutral
CAPITALCOM:EBS
by P-Ment4U
EBS Base Breakout SetupHey everybody got my camera working for this trade idea. Here we have the ebs stock setting up for a breakout in an uptrend and we're hoping for a bullish continuation here. I describe my entry points my stop loss and my profit target one and the logic behind them and how to position your share count so you can manage your risk and prepare to lose as much or as little money that you want if the trade goes against you every decision in this trade has meaning and logic to it that pertains to the particular stock and the setup therefore you know why you are doing everything that you're doing when trading. Let me know if you have any questions or if this is new to you or if you need help setting it up or calculating how much money you should win or lose. The only issue with this stock is that it's not in the technology sector and it's not in the communication sector so it is not in the most high performing sector right now although the healthcare sector is performing pretty decently with financials as well.
Editors' picks
NYSE:EBSEducation
by PappyTrading
4
EBS a biotech company focused on vaccinesEBS is a small biotechnology company whose forte is the clean processing and manufacturing facility that the FDA requires for certain bioprocessing to be certified for delivery of products to end-user patients. It is not a research facility like the one in China that accidentally released COVID and the global impact will be likely felt for another decade. EBS does depend on federal support and income from contract work from vaccine manufacturers. There is reasonable expectation or persistent and consistent revenues ongoing without fail unless the FDA decertified the facilities. On the chart, EBS is in a flat bottom triangle on its base. It is presently rising out of the triangle and towards the mean anchored VWAP It is just above The POC line which functions as dynamic support in the demand zone. I see a long trade with the stop loss below the POC line, the first target the blue line representing one standard deviation above the mean VWAP at about 9.4 while the second target is the redline two standard deviations above the mean VWAP at about 10.05 while the final target contemplates that EBS will challenge the high in May of 10.75.
NYSE:EBS
by AwesomeAvani
Is EBS a buy as it hits a critical support level? EBS is currently hitting a critical support level around the 25 levels, which has been tested multiple times as key support and resistance level since 2009. I am planning on buying at this current level, with a very high-profit target and a tight 5% stop loss below the support level. The ATH is over 400% above the current price, so there's a lot of upside potential in this trade, but it will need to be managed carefully since the market is in a downtrend right now.
NYSE:EBSLong
by spiritualhealer117
EBS: It's pretty bad when you underperform TNXPConsidering TNXP does... well... nothing, EBS underperforming TNXP is disappointing. Still holding and will continue to buy shares if SP falls back into the gray area at $25-$32. Monthly hammer + continuation off a high volume node + 2.618 fib should indicate a trend reversal. EBS was never a "squeeze" play because it's already worth a billion dollars. Additionally, I don't believe monkey pox is a serious pandemic regardless of what WHO says. EBS still has a pipeline of drugs that generates revenue and profit. With or without Monkey Pox, EBS should see $50-$60 (fibs) imo.
NYSE:EBSLong
by CrashWhen
EBS possible setup with 2 major supports EBS looks like a solid buy, I am investing at current price, if it goes down then I will add around second support. Reasons to buy: RSI looks oversold Stock trading at long term trendline 2021 consensus earning estimate 9.01 which means 7~ PE. Volume is increasing which shows it is getting attention Once the FDA will approve its facility, it will fly. Also, even if it breaks current level 2nd huge support level is not that far. So, doesn't have much to loose.
NYSE:EBSLong
by a4ankurbhutani
Pull Back Fishing Falling WedgeBullish engulfing candle today. The .886 fib level may have been the landing pad, but the bottom is not always the bottom. Biotech has been up and down so I am approaching this sector with caution for now. I have noted some biotech making daily or every other day yearly low and EBS made a new low yesterday and today although the 2 lows almost matched 58.79 today and 58.83 yesterday. Negative volume is high. Short interest is 7.2% Possible bullish divergence on RSI. No recommendation
NYSE:EBS
by lauralea